Acute probucol treatment partially restores vasomotor activity and abnormal lipid metabolism whereas morphological changes are not affected in aorta from long-term STZ-diabetic rats

被引:11
作者
Karasu, C [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmacol, TR-06100 Tandogan, Ankara, Turkey
关键词
rat aorta; probucol; streptozotocin-diabetes; vasomotor activity; morphology;
D O I
10.1055/s-0029-1211975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of acute probucol treatment on plasma lipids, lipid peroxides and vasomotor activity and structure of aorta were investigated in long-term streptozotocin (STZ)-diabetic rats. Treatment with probucol (300 mg/kg/day, i.o.) was initiated 10 weeks after the induction of diabetes and was continued for 2 or 3 weeks. Plasma cholesterol, triglyceride and thiobarbituric acid reactive substance (TBARS) levels were markedly increased in untreated diabetic rats, however, probucol treatment led to significant reductions in all of these characteristics in diabetic animals. Plasma glucose and insulin levels were similar between untreated and probucol-treated diabetic groups. STZ-diabetes impaired morphological integrity of aorta and caused significanty increase in contractile response to noradrenaline (NA). The percentage of endothelial response (PER), which was calculated in terms of the NA-induced maximum contractile response of aorta, as index of endothelial function, significantly decreased in untreated diabetic rats. Treatment of diabetic rats with probucol resulted in partial restorations in endothelial function and NA-induced contraction in aorta, whereas morphological changes were not affected. These observations suggest that the ability of acute probucol treatment to restore vessel functions may have important implications regarding the pathogenesis and treatment of diabetes and its complications.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 35 条
[1]   ENHANCED CONTRACTILE RESPONSES OF ARTERIES FROM DIABETIC RATS TO ALPHA-1-ADRENOCEPTOR STIMULATION IN THE ABSENCE AND PRESENCE OF EXTRACELLULAR CALCIUM [J].
ABEBE, W ;
HARRIS, KH ;
MACLEOD, KM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (02) :239-248
[2]   DIFFERENCES IN VASCULAR-RESPONSES TO VASOACTIVE AGENTS OF BASILAR ARTERY AND AORTA FROM RABBITS WITH ALLOXAN-INDUCED DIABETES [J].
ABIRU, T ;
KAMATA, K ;
MIYATA, N ;
KASUYA, Y .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (07) :882-888
[3]   RABBIT AORTIC SMOOTH-MUSCLE CELL-CULTURE - A MODEL FOR THE PHARMACOLOGICAL STUDY OF DIABETES-INDUCED ALTERATIONS IN CELL-PROLIFERATION [J].
ALIPUI, C ;
TENNER, TE ;
RAMOS, K .
JOURNAL OF PHARMACOLOGICAL METHODS, 1991, 26 (03) :211-222
[4]   PROBUCOL, A SUPEROXIDE FREE-RADICAL SCAVENGER INVITRO [J].
BRIDGES, AB ;
SCOTT, NA ;
BELCH, JJF .
ATHEROSCLEROSIS, 1991, 89 (2-3) :263-265
[5]   ANTIOXIDANT AND PROOXIDANT EFFECTS ON NERVE-CONDUCTION VELOCITY, ENDONEURIAL BLOOD-FLOW AND OXYGEN-TENSION IN NONDIABETIC AND STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
ARCHIBALD, V ;
DINES, KC ;
MAXFIELD, EK .
DIABETOLOGIA, 1994, 37 (05) :449-459
[6]  
CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992
[7]  
COHEN RA, 1993, CIRCULATION, V87, P67
[8]   EFFECT OF PROBUCOL ON DEVELOPMENT OF DIABETES-MELLITUS IN BB RATS [J].
DRASH, AL ;
RUDERT, WA ;
BORQUAYE, S ;
WANG, R ;
LIEBERMAN, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (03) :B27-B30
[9]  
GUIGLIANO D, 1995, METABOLISM, V44, P363
[10]  
GUIGLIANO D, 1996, DIABETES CARE, V19, P257